Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06981364 · ClinicalTrials.gov registry record · NA
Minimum Time Effect of Fish Oil on Arterial Stiffness
A NA study of Arterial Stiffness, sponsored by Salisbury University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT06981364: Completed NA study of Arterial Stiffness, sponsored by Salisbury University.
NCT06981364 is a NA study of Arterial Stiffness that has completed, run by Salisbury University. The registered enrollment target is 26 participants, below the 121-participant average among 12 other Arterial Stiffness trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06981364, a NA study of Arterial Stiffness, has completed, sponsored by Salisbury University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will seek to determine the minimum time of 4 g/day fish oil supplementation to cause a clinically significant effect on arterial stiffness. Accordingly, 30 moderately active, otherwise healthy adult subjects who are not currently taking any dietary supplementations will be recruited for the study. They will be randomized in a double-blind fashion into one of two groups: placebo group or fish oil dietary supplementation group. Subjects will either receive 4 g/day fish oil or placebo for 6 weeks. Each subject will undergo a series of baseline and follow-up tests including anthropometry, ultrasonography of the carotid artery, applanation tonometry, and blood pressure acquisition at week 0, 2, 4, and 6. Subjects will be required to maintain an activity and food log. Subjects will be asked to maintain their normal activity pattern during the study period. Repeated measures analysis of variance will be used to examine the effects of treatment and the treatment-order interaction on arterial stiffness (and other dependent variables).
Primary Outcome
The primary outcome of the proposed study will be beta-stiffness which is calculated from maximal and minimal carotid diameters and carotid systolic and diastolic pressures.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Fish Oil
Study Locations (1)
Maryland
- Salisbury University - Salisbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2022-10-01 |
| Est. Completion | 2023-01-05 |
| Phase | NA |
What the finished NCT06981364 record still lists
NCT06981364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 121-participant average among 12 other Arterial Stiffness trials with a reported enrollment target (79% lower).
The record links to 1 condition, with Arterial Stiffness appearing as the primary indexed condition, and to 1 intervention - of which Fish Oil is the first listed.
NCT06981364 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT06981364 about?
NCT06981364 is a clinical study titled "Minimum Time Effect of Fish Oil on Arterial Stiffness". This study will seek to determine the minimum time of 4 g/day fish oil supplementation to cause a clinically significant effect on arterial stiffness. Accordingly, 30 moderately active, otherwise healthy adult subjects who are not currently taking any dietary supplementations will be recruited for t...
What is the current status of trial NCT06981364?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2022-10-01. Estimated completion is 2023-01-05.
What conditions does trial NCT06981364 study?
This clinical trial studies the following conditions: Arterial Stiffness.
What interventions are being tested in trial NCT06981364?
The interventions under investigation include: Fish Oil (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06981364?
This trial is sponsored by Salisbury University, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06981364 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Arterial Stiffness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06981364's enrollment target sits among peer trials
26 10th of 12 higher than 3 of 12 other Arterial Stiffness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Arterial Stiffness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
-
Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes
RECRUITING · NA
-
Prebiotic Effects of California Grapes on Gut Health and Cardiometabolic Health in Overweight Men and Women
RECRUITING · NA
-
Effects of Sodium Intake on Arterial Stiffness in Black Men and Women
COMPLETED · NA
-
Role of Mitochondrial-derived Oxidative Stress to Promote Vascular Endothelial Dysfunction in Non-exercisers With Aging
COMPLETED · NA
-
Coconut Sugar Lowers Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI